Liposomal doxorubicin vs epirubicin in breast cancer

By  

Inpharma, Vol. 1, Iss. 1462, 2004-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Optimal therapy for platinum-resistant recurrent ovarian cancer: doxorubicin, gemcitabine or topotecan?

By Pectasides Dimitris   Psyrri Amanda   Pectasides Melina   Economopoulos Theofanis  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 8, 2006-06 ,pp. : 975-987

Informa Healthcare

Access to resources Recommend Favorite

Doxorubicin liposomal in ovarian cancer guidance issued by UK NICE

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 374, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Pegylated Liposomal Doxorubicin: A Review of its use in Metastatic Breast Cancer, Ovarian Cancer, Multiple Myeloma and AIDS-Related Kaposi's Sarcoma

By Duggan Sean T.   Keating Gillian M.  

Drugs, Vol. 71, Iss. 18, 2011-12 ,pp. : 2531-2558

Adis International

Access to resources Recommend Favorite

Liposomal doxorubicin effective for advanced breast cancer

By  

Inpharma, Vol. 1, Iss. 1460, 2004-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite